Company Filing History:
Years Active: 2024
Title: Heidrun Schott: Innovator in Antibody Research
Introduction
Heidrun Schott is a notable inventor based in Schemmerhofen, Germany. He has made significant contributions to the field of immunology, particularly in the development of antibodies that target PSGL-1. His work has implications for treating disorders associated with T cell activation.
Latest Patents
Heidrun Schott holds a patent for "Anti-PSGL-1 antibodies and uses thereof." This patent describes antibodies that specifically bind to PSGL-1, along with polynucleotides encoding these antibodies. The patent also includes expression vectors and host cells for producing the antibodies. Additionally, it outlines kits and pharmaceutical compositions that utilize these antibodies, as well as methods for treating diseases linked to increased T cell proliferation.
Career Highlights
Heidrun Schott is associated with Altrubio Inc., where he continues to advance research in antibody development. His innovative work has positioned him as a key figure in the field of therapeutic antibodies.
Collaborations
Heidrun collaborates with notable colleagues, including Stefan Bassarab and Barbara Enenkel, who contribute to the research and development efforts at Altrubio Inc.
Conclusion
Heidrun Schott's contributions to antibody research, particularly through his patent on Anti-PSGL-1 antibodies, highlight his role as an innovator in the field. His work has the potential to impact therapeutic approaches for diseases related to T cell activation.